EDGAR Filing Documents for 0001140361-20-012652

Form 424B2 - Prospectus [Rule 424(b)(2)]:

SEC Accession No. 0001140361-20-012652

Filing Date

2020-05-29

Accepted

2020-05-29 06:07:00

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	424B2	nt10011234x6_424b2.htm	424B2	730511
2		logo_biocryst2a.jpg	GRAPHIC	39608
3		logo_biocryst2ax1.jpg	GRAPHIC	48001
4		logo_biocryst2ax2.jpg	GRAPHIC	66123
	Complete submission text file	0001140361-20-012652.txt		942802

Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703

Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302

BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)